Brainfarma Indústria Química e Farmacêutica S/A
Clinical trials sponsored by Brainfarma Indústria Química e Farmacêutica S/A, explained in plain language.
Brazilian pharmaceutical company producing generic and branded medicines.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a new cosmetic pass the sensitive skin test? Results expected Sep 2026 (estimated)
- Can a daily cosmetic keep pores clear without irritation? Results expected Sep 2026 (estimated)
- Can a daily cream rebuild the Skin's barrier? trial puts moisturizer to the test Results expected Nov 2026 (estimated)
- A new gel aims to fade dark Spots—Will it deliver a brighter complexion? Results expected Jan 2027 (estimated)
- Could a Once-Daily pill ease nerve pain just as well as the standard Twice-Daily dose? Results expected Jun 2027 (estimated)